This is good news. Looks like two trials from the Barrow institute to assess 5-ALA fluorescence agent with confocal microscope in brain surgery. This would be the phase 3 confirmatory trial. The primary completion date may have already passed
Column 1 Column 2 0 Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)
https://www.clinicaltrials.gov/ct2/...urgery for Low- and High-grade Gliomas&rank=1
http://www.cancer.gov/clinicaltrials/search/view?cdrid=721822&version=Patient
https://www.clinicaltrials.gov/ct2/...urgery for Low- and High-grade Gliomas&rank=2
https://www.clinicaltrials.gov/ct2/...or Low- and High-grade Gliomas &Search=Search
Whatever the traders are doing atm won`t matter with positive outcomes from these trials.
- Forums
- ASX - By Stock
- OIL
- phase three trials
OIL
optiscan imaging limited
Add to My Watchlist
1.19%
!
8.5¢

phase three trials
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
8.5¢ |
Change
0.001(1.19%) |
Mkt cap ! $71.00M |
Open | High | Low | Value | Volume |
8.3¢ | 8.5¢ | 8.1¢ | $10.90K | 132.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 125000 | 8.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.6¢ | 60000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 125000 | 0.080 |
2 | 76500 | 0.079 |
2 | 130000 | 0.078 |
1 | 10000 | 0.075 |
1 | 41680 | 0.071 |
Price($) | Vol. | No. |
---|---|---|
0.086 | 60000 | 1 |
0.090 | 15000 | 1 |
0.092 | 50000 | 1 |
0.095 | 50000 | 1 |
0.100 | 103621 | 2 |
Last trade - 15.36pm 19/09/2025 (20 minute delay) ? |
Featured News
OIL (ASX) Chart |